期刊文献+

组胺受体3拮抗剂对神经病理性疼痛的治疗作用

Effect of histamine receptor 3 antagonists on neuropathic pain
下载PDF
导出
摘要 目的探讨脑室内注射组胺受体3拮抗剂对神经病理性疼痛大鼠的治疗作用。方法选择左侧坐骨神经部分结扎致神经病理性疼痛大鼠30只,脑室内给药。大鼠随机分为脑室内对照组、脑室内组胺受体3(H3R)拮抗剂-thioperamide组(50μg)、脑室内H3R激动剂R-α-甲基组胺组(RAMH,4μg),评价注药后痛阈的改变。结果与对照组相比,脑室内给予thioperamide 10min后起效,持续至100min,能显著提高大鼠对机械性刺激的痛阈(P﹤0.01),缓解疼痛。同时予RAMH30~50min后引起疼痛且能加重痛觉过敏(P﹤0.05)。结论神经病理性疼痛时,采用组胺受体3拮抗剂脑室内给药能提高痛阈,可以缓解疼痛。 Objective To investigate the effect of histamine receptor 3 agonist and antagonist on mechanical pain threshold of neuropathic pain rat and to find out whether there is an antinociceptive effect of histamine receptor 3 ligands on neuropathic pain. Methods In rats, the sciatic nerve was partially ligated and neuropathic pain were induced. Two weeks later, histamine receptor 3 agonist-R-α-methylhistamine and antagonists-thioperamide, and saline were respectively injected intracerebroventricularly into neuropathic pain rats and the effect of these medicine on mechanical pain threshold were measured. Results There was signifigant increase of the pain threshold in the thioperamide group, on the other hand, R-α-methylhistamine significantly decreased the pain threshold compared with the control group, which aggravated the hyperpalgesia in rats with neuropathic pain. Conclusions Intracerebroventricular administration of histamine receptor 3 antagonist can induce antinociception in rats with neumpathic pain.
作者 黄亮 長櫓巧
出处 《北京医学》 CAS 2008年第10期589-591,共3页 Beijing Medical Journal
基金 日本笹川医学研究者资助项目
关键词 组胺 神经痛 受体 Histamine Neuropathic pain Receptor
  • 相关文献

参考文献10

  • 1黄亮,足立尚登,长橹巧,新井达.神经病理性疼痛大鼠纹状体组胺水平的变化及脑室内注射组胺的效果[J].中华麻醉学杂志,2006,26(6):542-546. 被引量:4
  • 2Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci, 2003, 4:121 - 130.
  • 3Wuff BS, Hastrup S, Rimvall K. Characterization of recombinantly expressed rat and human histamine H3 receptor. Eur J Pharmacol, 2002, 453:33 - 41.
  • 4Cannon KE, Hough LB. Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. J Pain, 2005, 6:193 - 200.
  • 5Farzin D, Asghari L, Nowrouzi M. Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol Biochem Behav, 2002, 72:751 - 760.
  • 6Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Rev, 2004, 46 : 295 - 309.
  • 7Collins SD, ChesseU IP.Emerging therapies for neuropathic pain. Expert Opin Emerg Drugs, 2005, 10:95 - 108.
  • 8Cannon KE, Chazot PL, Hann V, et al. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord:Potential antinociceptive targets. Pain, 2007, 129:76 - 92.
  • 9Alguacil LF, Perez-Gareia C. Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders. Curr Drug Targets CNS Neurol Disord, 2003, 2:303 - 313.
  • 10Romanelli P, Esposito V. The functional anatomy of neuropathic pain. Neurosurg Clin North Am, 2004, 15:257 - 268.

二级参考文献10

  • 1Gherlardini C, Galeotti N, Bartolini A. No development of tolerance to analgesia by repeated administration of H1 antagonists. Life Sci, 1998,63 : 317-322.
  • 2Malmberg Aiello P. Lamberti C, Ghelardini C. et al. Role of histamine in rodent antinociception. Br J Pharmaeol, 1994,111: 1269-1279.
  • 3Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain,1990,43: 205-218.
  • 4Itoh Y, Oishi R, Adachi N, et al. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization:its application to hiological specimens. J Neurechem, 1992, 58: 884-889.
  • 5Chaplan SR, Bach FW, Pogrel JW. et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994,53:55-63.
  • 6Adachi N, Itoh Y, Oishi R. et al. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J Cereb Blood Flow Metab,1992,12:477-483.
  • 7Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci, 2003,4: 121-130.
  • 8Horton JR, Sawada K, Nishibori M, et al. Structural basis for inhibition of histamine N-methyltransferase by diverse drug. J Mol Biol, 2005,353:334-344.
  • 9Duch DS, Bowers SW, Nichol CA. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochem Pharmacol, 1978.27: 1507-1509.
  • 10Schwartz JC, Lampart C, Rose C. Histamine formation in rat brain in vivo: effects of histidine loads. J Neurochem, 1972,19: 801-810.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部